Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune-related adverse events during treatment with immune checkpoint inhibitors

DSpace Repositorium (Manakin basiert)

Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune-related adverse events during treatment with immune checkpoint inhibitors

Autor(en): Schmitt, Christina; Mueller, Katharina J.; Tiedt, Steffen; Kramer, Nora; Manger, Isabel; Knauss, Samuel; Mueller-Jensen, Leonie; Huehnchen, Petra; Boehmerle, Wolfgang; Schoeberl, Florian; Heinzerling, Lucie; von Baumgarten, Louisa
Tübinger Autor(en):
Baumgarten, Louisa von
Erschienen in: International Journal of Cancer (2025), Bd. 156, H. 10, S. 1961-1971
Verlagsangabe: Hoboken : Wiley
Sprache: Englisch
Referenz zum Volltext: http://dx.doi.org/10.1002/ijc.35328
ISSN: 0020-7136
DDC-Klassifikation: 610 - Medizin, Gesundheit
Dokumentart: Wissenschaftlicher Artikel
Zur Langanzeige

Das Dokument erscheint in: